Results 181 to 190 of about 21,622 (232)

Exercise and Physical Activity as Modifiable Risk Factors for Benign Prostatic Hyperplasia: An Update. [PDF]

Curr Urol Rep
Branco F, Rocha-Rodrigues S, Ribal MJ, Ribeiro R.   +3 more
europepmc   +1 more source

Mediation analysis of adherence to pelvic floor muscle training and weekly self-monitoring on urinary symptoms in men with localized prostate cancer A secondary analysis of the Prostate Cancer-Patient Empowerment Program (PC-PEP) randomized controlled trial. [PDF]

Can Urol Assoc J
Chedrawe E, Smith NK, Ilie G, Rendon RA, Mason R, Kokorovic A, MacDonald C, Patil N, Bowes D, Bailly G, Abou-Samra E, Bourne A, Hagerman LP, Rutledge R.   +13 more
europepmc   +1 more source

A comparative study of thulium fiber laser and holmium:YAG laser for prostate enucleation: a systematic review and meta-analysis. [PDF]

J Lasers Med Sci
Luangtangvarodom P, Harirugsakul K, Usawachintachit M, Susantitaphong P, Sainont G.   +4 more
europepmc   +1 more source

Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence. [PDF]

Drugs Context
Schwartzmann I, Redondo A, Farré A, Izquierdo P, Moncada E, Montlleó M, Quiroz Y, Breda A, Palou J, de León JP.   +9 more
europepmc   +1 more source

Role of Pre-procedural MRI Parameters and Urodynamic Findings in Predicting Clinical Success After Prostate Artery Embolization. [PDF]

Cureus
Nayyer Z, Shafiq M, Anwar S, Thomas N, Chandra R, Mae Bailey GL, Imran Hossain M, Subhash Joshi P, Chaudhary MH.   +8 more
europepmc   +1 more source

Indian Psychiatric Survey Schedule (IPSS) [PDF]

Social Psychiatry, 1974
The paper describes the development of Indian Psychiatric Survey Schedule (IPSS) which is designed to inquire about the presence of 124 psychiatric symptoms and 10 items of historical information in the general population. The symptoms as well as the items of historical information are the same as those in IPIS (Kapur et al., 1974) but because of a ...
R. L. Kapur, Malavika Kapur, G. M. Carstairs   +2 more
openaire   +2 more sources

Impact of IPSS-M implementation in real-life clinical practice [PDF]

Frontiers in Oncology, 2023
ObjectivesThe IPSS-M is a recently published score for risk stratification in myelodysplastic syndromes (MDS), based on clinical and molecular data. We aimed to evaluate its relevance on treatment choice in a real-life setting.MethodsWe retrospectively ...
Joaquin Martínez-López, Rosa María Ayala Diaz, Inmaculada Rapado   +2 more
exaly   +2 more sources

System Design of E-Markets for IPSS Purchasing

Procedia CIRP, 2017
The production of labor cost intense goods in industrial countries becomes increasingly unprofitable, unless add-on values can be delivered by supporting services.
Jürgen Dorn
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Comparison of International Prognostic Scoring System (IPSS) and Revised IPSS (IPSS-R) in myelodysplastic syndromes (MDS).

Journal of Clinical Oncology, 2016
e18549 Background: IPSS and IPSS-R stratifies MDS patients into low- to high-risk groups based on karyotype, bone marrow myeloblasts and cytopenias. We report the comparison of IPSS and IPSS-R in predicting overall survival (OS) in MDS patients.
Muhammad Umair Mushtaq, Abdullah Ali, Kiyomi Morita, Ronald Pinheiro, Muhammad Baig, Azra Raza   +5 more
openaire   +1 more source

Caution during use of desmopressin in IPSS

Journal of NeuroInterventional Surgery, 2012
We thank Dr Pecori Giraldi and colleagues for their letter concerning caution during the use of desmopressin in inferior petrosal sinus sampling (IPSS). The authors suggest that, because of the hypercoagulable state that characterizes Cushing's disease, desmopressin may not be safe since it has been shown to increase the level of von Willebrand factor ...
Amy R, Deipolyi, Joshua A, Hirsch, Rahmi, Oklu   +2 more
openaire   +5 more sources